BioCryst Pharmaceuticals, Inc. Non-operating Interest Expenses

Non-operating Interest Expenses of BCRX for past 10 years: annual, quarterly and twelve month trailing (TTM) including Non-operating Interest Expenses growth rates and interactive chart. Interest expense that is usually non-recurring and not tied to a company's operations. It is stated separately on the income statement to differentiate it from interest expenses.


Highlights and Quick Summary

  • Non-operating Interest Expenses for the quarter ending September 30, 2022 was $24.8 Million (a 3.13% increase compared to previous quarter)
  • Year-over-year quarterly Non-operating Interest Expenses increased by 31.92%
  • Annual Non-operating Interest Expenses for 2021 was $61 Thousand (a -88.4% decrease from previous year)
  • Annual Non-operating Interest Expenses for 2020 was $526 Thousand (a -72.79% decrease from previous year)
  • Annual Non-operating Interest Expenses for 2019 was $1.93 Million (a -14.09% decrease from previous year)
  • Twelve month Non-operating Interest Expenses ending September 30, 2022 was $91.4 Million (a 13.2% increase compared to previous quarter)
  • Twelve month trailing Non-operating Interest Expenses increased by 54.17% year-over-year
Trailing Non-operating Interest Expenses for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
$91.4 Million $80.8 Million $70.2 Million $59.3 Million
Visit stockrow.com/BCRX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Non-operating Interest Expenses of BioCryst Pharmaceuticals, Inc.

Most recent Non-operating Interest Expensesof BCRX including historical data for past 10 years.

Interactive Chart of Non-operating Interest Expenses of BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc. Non-operating Interest Expenses for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $24.78 $24.02 $23.84
2021 $18.78 $14.12 $13.5 $12.9 $0.06
2020 $5.61 $2.93 $2.92 $3.05 $0.53
2019 $3.09 $3.04 $3.04 $2.73 $1.93
2018 $2.41 $2.35 $2.2 $2.22 $2.25
2017 $2.23 $2.14 $2.09 $2.1 $1.01
2016 $2.13 $1.47 $1.42 $1.47 $6.49
2015 $1.34 $1.24 $1.31 $1.32 $5.2
2014 $1.31 $1.22 $1.23 $1.24 $5.0
2013 $1.24 $1.19 $1.17 $1.18 $4.78
2012 $1.18 $1.17 $1.16 $1.16 $4.67

Business Profile of BioCryst Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology